One study, however, by Díaz et al. analysed the EGFL7 mRNA expression in 110 patients with CRC stage I-IV, and demonstrated a significantly higher EGFL7 mRNA expression in stage III and IV than in stage I and II tumours, which supports the present results [11]. Here, EGFL7 is linked to neoplasm.